Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.430 | None | 1.000 | 4 | 2 | 2018 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 0 | 0 | |||||||||||
|
endoglin | 0.446 | 0.846 | 1.00 |
|
group | 0.150 | None | 1.000 | 5 | 2 | 2000 | 2013 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
group | 0.130 | None | 1.000 | 3 | 0 | 2004 | 2018 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
programmed cell death 10 | 0.631 | 0.692 | 0.96 |
|
group | 0.100 | None | 0 | 1 | |||||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | ||||||||
|
secretory leukocyte peptidase inhibitor | 0.449 | 0.846 | 9.0E-04 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2018 | ||||||||
|
SMG8 nonsense mediated mRNA decay factor | 0.780 | 0.346 | 7.3E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
spermine synthase | 0.491 | 0.846 | 0.97 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
thrombospondin 1 | 0.407 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
platelet derived growth factor D | 0.579 | 0.538 | 1.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
phosphate cytidylyltransferase 1, choline, alpha | 0.485 | 0.885 | 2.0E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
competing endogenous lncRNA 3 for miR-645 | 0.531 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
nestin | 0.450 | 0.808 | 1.6E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
collagen type IV alpha 2 chain | 0.563 | 0.654 | 3.6E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
Russell Silver syndrome | 0.578 | 0.692 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |